Stock NARI INARI MEDICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Inari Medical, Inc.

Equities

NARI

US45332Y1091

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-14 pm EDT 		5-day change 1st Jan Change
45.5 USD -0.18% Intraday chart for Inari Medical, Inc. +6.28% -29.91%
May. 03 Inari Medical Insider Sold Shares Worth $1,619,047, According to a Recent SEC Filing MT
May. 01 Inari Medical Shares Jump on Higher Q1 Revenue MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
INARI MEDICAL SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Inari Medical, Inc. - NARI
BU
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Inari Medical, Inc. (NARI) Investors
BU
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inari Medical
PR
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NARI
PR
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NARI
BU
Grant & Eisenhofer Files Class Action Lawsuit Against Inari Medical, Inc. on Behalf of Institutional Investor
BU
Inari Medical to Participate in the 2024 Bank of America Securities Healthcare Conference
AQ
Inari Medical : April 2024 Inari Medical Investor Presentation
PU
Inari Medical Reports First Quarter 2024 Financial Results
AQ
Inari Medical to Announce First Quarter 2024 Financial Results
AQ
Inari Medical Announces the Release of 2023 Ethos and Sustainability Report
AQ
Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives
AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Inari Medical, Inc.- NARI
PR
Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry
AQ
Inari Medical Investigation: Kessler Topaz Meltzer & Check, LLP Investigates The Inari Medical, Inc. (NASDAQ: NARI) for Potential Securities Violations
PR
Inari Medical, Inc. (NARI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
BU
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Inari Medical, Inc. (NARI) on Behalf of Investors
BU
Law Offices of Howard G. Smith Announces Investigation of Inari Medical, Inc. (NARI) on Behalf of Investors
BU
The Law Offices of Frank R. Cruz Announces Investigation of Inari Medical, Inc. (NARI) on Behalf of Investors
BU
Inari Medical, Inc. (NARI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NARI Stock
  4. News Inari Medical, Inc.
  5. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW